loadpatents
name:-0.04572582244873
name:-0.035543918609619
name:-0.011642932891846
Zeng; Qingbei Patent Filings

Zeng; Qingbei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zeng; Qingbei.The latest application filed is for "dna-dependent protein kinase inhibitor".

Company Profile
8.30.36
  • Zeng; Qingbei - Shanghai CN
  • Zeng; Qingbei - Edison NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
ERBB receptor inhibitors
Grant 11,447,492 - Li , et al. September 20, 2
2022-09-20
Dna-dependent Protein Kinase Inhibitor
App 20220242884 - QI; Changhe ;   et al.
2022-08-04
Jak1 Selective Kinase Inhibitor
App 20220220096 - QI; Changhe ;   et al.
2022-07-14
Pyrazine Compounds And Uses Thereof
App 20210251989 - QI; Changhe ;   et al.
2021-08-19
Pyrazine compounds and uses thereof
Grant 10,898,481 - Qi , et al. January 26, 2
2021-01-26
Triazolo-pyrimidine Compounds And Uses Thereof
App 20210009600 - ZENG; Qingbei ;   et al.
2021-01-14
Erbb Receptor Inhibitors
App 20210009587 - LI; Zhengtao ;   et al.
2021-01-14
Triazolo-pyrimidine compounds and uses thereof
Grant 10,858,365 - Zeng , et al. December 8, 2
2020-12-08
ErbB receptor inhibitors
Grant 10,822,334 - Li , et al. November 3, 2
2020-11-03
Pyrazine Compounds And Uses Thereof
App 20200330458 - QI; Changhe ;   et al.
2020-10-22
Triazolo-pyrimidine Compounds And Uses Thereof
App 20200331918 - ZENG; Qingbei ;   et al.
2020-10-22
Erbb Receptor Inhibitors
App 20200317669 - LI; Zhengtao ;   et al.
2020-10-08
Quinazoline Inhibitors Of Activating Mutant Forms Of Epidermal Growth Factor Receptor
App 20180016259 - Li; David Yunzhi ;   et al.
2018-01-18
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
Grant 9,718,806 - Li , et al. August 1, 2
2017-08-01
Quinazoline Inhibitors Of Activating Mutant Forms Of Epidermal Growth Factor Receptor
App 20160340342 - LI; David Yunzhi ;   et al.
2016-11-24
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
Grant 9,375,432 - Li , et al. June 28, 2
2016-06-28
Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor
App 20150320751 - Li; David Yunzhi ;   et al.
2015-11-12
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
Grant 9,066,979 - Li , et al. June 30, 2
2015-06-30
Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C
Grant 8,980,920 - Zeng , et al. March 17, 2
2015-03-17
Silyl-containing Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20150057246 - Dwyer; Michael P. ;   et al.
2015-02-26
Silyl-containing Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20140378416 - Dwyer; Michael P. ;   et al.
2014-12-25
Tricyclic indole derivatives and methods of use thereof
Grant 8,901,139 - Venkatraman , et al. December 2, 2
2014-12-02
Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor
App 20140255428 - LI; David Yunzhi ;   et al.
2014-09-11
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C
Grant 8,772,505 - Chen , et al. July 8, 2
2014-07-08
Substituted indole derivatives and methods of use thereof
Grant 8,614,229 - Anilkumar , et al. December 24, 2
2013-12-24
Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases
Grant 8,609,635 - Nair , et al. December 17, 2
2013-12-17
4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
Grant 8,557,848 - Chen , et al. October 15, 2
2013-10-15
Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C
App 20130164258 - Chen; Kevin X. ;   et al.
2013-06-27
Antiviral Compounds Of Three Linked Aryl Moieties To Treat Diseases Such As Hepatitis C
App 20120258078 - Zeng; Qingbei ;   et al.
2012-10-11
Heterocyclic substituted piperazines with CXCR3 antagonist activity
Grant 8,207,170 - Kim , et al. June 26, 2
2012-06-26
Heterocyclic Compounds With Cxcr3 Antagonist Activity
App 20120157466 - Zeng; Qingbei ;   et al.
2012-06-21
2,3-substituted indole derivatives for treating viral infections
Grant 8,143,305 - Anilkumar , et al. March 27, 2
2012-03-27
Fused Tricyclic Silyl Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20110223134 - Nair; Anilkumar Gopinadhan ;   et al.
2011-09-15
Tricyclic Indole Derivatives And Methods Of Use Thereof
App 20110189127 - Venkatraman; Srikanth ;   et al.
2011-08-04
Tetracyclic Indole Derivatives And Their Use For Treating Or Preventing Viral Infections
App 20110104109 - Bennett; Frank ;   et al.
2011-05-05
Substituted Indole Derivatives And Methods Of Use Thereof
App 20110104110 - Anikumar; Gopinadhan N. ;   et al.
2011-05-05
Heterocyclic Substituted Piperazines With Cxcr3 Antagonist Activity
App 20110065651 - Kim; Seong Heon ;   et al.
2011-03-17
2,3-substituted Indole Derivatives For Treating Viral Infections
App 20110033417 - Anilkumar; Gopinadhan N. ;   et al.
2011-02-10
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
Grant 7,879,838 - Zeng , et al. February 1, 2
2011-02-01
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
Grant 7,868,005 - Rosenblum , et al. January 11, 2
2011-01-11
Heterocyclic substituted piperazines with CXCR3 antagonist activity
Grant 7,868,006 - Kim , et al. January 11, 2
2011-01-11
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
Grant 7,799,789 - Anilkumar , et al. September 21, 2
2010-09-21
4,5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections
App 20100098661 - Chen; Kevin X. ;   et al.
2010-04-22
Novel Heterocyclic Substituted Pyridine Or Phenyl Compounds With Cxcr3 Antagonist Activity
App 20080292589 - Anilkumar; Gopinadhan N. ;   et al.
2008-11-27
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
Grant 7,417,045 - Anilkumar , et al. August 26, 2
2008-08-26
Piperidine compounds
Grant 7,238,688 - Rosenblum , et al. July 3, 2
2007-07-03
Benzimidazolone histamine H.sub.3 antagonists
Grant 7,220,735 - Ting , et al. May 22, 2
2007-05-22
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity
App 20070054919 - Rosenblum; Stuart B. ;   et al.
2007-03-08
Heterocyclic substituted piperazines with CXCR3 antagonist activity
App 20060276479 - Kim; Seong Heon ;   et al.
2006-12-07
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
App 20060276448 - Zeng; Qingbei ;   et al.
2006-12-07
Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
App 20060217392 - Anilkumar; Gopinadhan N. ;   et al.
2006-09-28
Benzimidazole derivatives useful as histamine H3 antagonists
Grant 7,105,505 - Zeng , et al. September 12, 2
2006-09-12
Novel non-imidazole compounds
App 20050113383 - Rosenblum, Stuart B. ;   et al.
2005-05-26
Piperidine compounds
Grant 6,849,621 - Rosenblum , et al. February 1, 2
2005-02-01
Benzimidazole derivatives useful as histamine H3 antagonists
App 20040097483 - Zeng, Qingbei ;   et al.
2004-05-20
Benzimidazolone histamine H3 antagonists
App 20040048843 - Ting, Pauline C. ;   et al.
2004-03-11
Novel non-imidazole compounds
App 20030109564 - Rosenblum, Stuart B. ;   et al.
2003-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed